What is the recommendation for the pneumococcal vaccine for cardiovascular patients?
The pneumococcal vaccine is recommended for patients 65 years of age and older and in high-risk patients with cardiovascular disease. Vaccination with the 23-valent pneumococcal polysaccharide vaccine is recommended for all adults 65 years of age. Adults of any age who are at increased risk, including smokers and those with asthma, should also be given the vaccine.